Prothena Corp Public (PRTA) Tax Provisions (2012 - 2026)
Prothena Corp Public (PRTA) posted quarterly Tax Provisions of $1000.0 for Q1 2026, up 100.08% year-over-year from $499.79 in Q1 2025, and up 102.7% quarter-over-quarter from -$37000.0 in Q4 2025.
Prothena Corp Public (PRTA) Tax Provisions (2012 - 2026) Analysis & Trends
Prothena Corp Public's Tax Provisions history runs 15 years deep, the most recent figure standing at $1000.0 for Q1 2026.
- In Q1 2026, Tax Provisions rose 100.08% year-over-year to $1000.0; the TTM figure through Mar 2026 stood at $44.4 million (up 906.95% YoY), while the FY2025 annual figure was $43.3 million, up 753.52% from the prior year.
- Tax Provisions for Q1 2026 stood at $1000.0, up from -$37000.0 in the prior quarter.
- The five-year high for Tax Provisions was $44.8 million in Q2 2025, with the low at -$4.3 million in Q2 2023.
- The 5-year median for Tax Provisions is -$1.7 million (2022), against an average of $855882.4.
- The sharpest annual moves came in 2022 and 2025: Tax Provisions sank 6630.43% in 2022, then jumped 2340.1% in 2025.
- Prothena Corp Public's Tax Provisions stood at -$3.0 million in 2022, then declined by 4.59% to -$3.1 million in 2023, then soared by 51.62% to -$1.5 million in 2024, then jumped by 97.57% to -$37000.0 in 2025, then soared by 102.7% to $1000.0 in 2026.
- Business Quant data shows PRTA's Tax Provisions at $1000.0 in Q1 2026, -$37000.0 in Q4 2025, and -$400000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Prothena Corp Public | 458.45 Mn | 170.25 Mn | - | 2,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2,000.00 |
| Mar 31, 2026 | 1,000.00 |
| Dec 31, 2025 | -37,000.00 |
| Sep 30, 2025 | -400,000.00 |
| Jun 30, 2025 | 44.80 Mn |
| Mar 31, 2025 | -1.18 Mn |
| Dec 31, 2024 | -1.52 Mn |
| Sep 30, 2024 | -800,000.00 |
| Jun 30, 2024 | -2.00 Mn |
| Mar 31, 2024 | -2.20 Mn |
| Dec 31, 2023 | -3.14 Mn |
| Sep 30, 2023 | -3.10 Mn |
| Jun 30, 2023 | -4.30 Mn |
| Mar 31, 2023 | -2.90 Mn |
| Dec 31, 2022 | -3.00 Mn |
| Sep 30, 2022 | -2.70 Mn |
| Jun 30, 2022 | -1.30 Mn |
| Mar 31, 2022 | -1.67 Mn |
| Dec 31, 2021 | 46,000.00 |
| Sep 30, 2021 | -51,000.00 |